Cancer Biology & Therapy

Papers
(The TQCC of Cancer Biology & Therapy is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Correction91
Tripartite motif-containing protein 50 suppresses triple-negative breast cancer progression by regulating the epithelial–mesenchymal transition57
Evaluating massage therapy for radiation-induced fibrosis in rats: preliminary findings and palpation results39
Correction39
Phase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteers38
Molecular profiles of different PD-L1 expression in patients with esophageal squamous cell carcinoma37
Clinical and biological determinants of circulating tumor DNA detection and prognostication using a next-generation sequencing panel assay34
Clinical application of molecular residual disease detection by circulation tumor DNA in solid cancers and a comparison of technologies: review article30
DDX24 regulates the chemosensitivity of hepatocellular carcinoma to sorafenib via mediating the expression of SNORA1829
miRNA-660-3p inhibits malignancy in glioblastoma via negative regulation of APOC1-TGFβ2 signaling pathway29
GdX inhibits the occurrence and progression of breast cancer by negatively modulating the activity of STAT326
CPT1A mediates the succinylation of SP5 which activates transcription of PDPK1 to promote the viability and glycolysis of prostate cancer cells26
Immunotherapy resistance in solid tumors: mechanisms and potential solutions26
Loss of ubiquitin-specific peptidase 18 destabilizes 14-3-3ζ protein and represses lung cancer metastasis26
Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy25
Small extracellular vesicle-mediated ITGB6 siRNA delivery downregulates the αVβ6 integrin and inhibits adhesion and migration of recipient prostate cancer cells24
Silencing ZIC5 suppresses glycolysis and promotes disulfidptosis in lung adenocarcinoma cells24
MiR-128-1-5p inhibits cell proliferation and induces cell apoptosis via targeting PRKCQ in colorectal cancer23
Partial treatment response to capmatinib in MET-amplified metastatic intrahepatic cholangiocarcinoma: case report & review of literature23
Linoleic acid exhibits anti-proliferative and anti-invasive activities in endometrial cancer cells and a transgenic model of endometrial cancer22
SATB1 mediated tumor colonization and β-catenin nuclear localization are associated with colorectal cancer progression22
Mutant PIK3CA as a negative predictive biomarker for treatment with a highly selective PIM1 inhibitor in human colon cancer20
Correction20
Bibliometric analysis of autophagy in the diagnosis and treatment of osteosarcoma: a bibliometric analysis (2007–2023)20
Antibody dependent cell-mediated cytotoxicity selection pressure induces diverse mechanisms of resistance20
Requirement for containing etoposide in the initial treatment of lymphoma associated hemophagocytic lymphohistiocytosis20
Aldolase A promotes cervical cancer cell radioresistance by regulating the glycolysis and DNA damage after irradiation19
Isolated pulmonary metastases in pancreatic ductal adenocarcinoma: a review of current evidence18
Nucleo-cytoplasmic shuttling of 14-3-3 epsilon carrying hnRNP C promotes autophagy18
PCBP1 regulates LIFR through FAM3C to maintain breast cancer stem cell self-renewal and invasiveness17
LINC01060 knockdown inhibits osteosarcoma cell malignant behaviors in vitro and tumor growth and metastasis in vivo through the PI3K/Akt s17
Autophagic degradation of CDK4 is responsible for G0/G1 cell cycle arrest in NVP-BEZ235-treated neuroblastoma17
CDH2 and CDH13 as potential prognostic and therapeutic targets for adrenocortical carcinoma16
Liu-Shen-Wan inhibits PI3K/Akt and TRPV1 signaling alleviating bone cancer pain in rats16
A positive feedback loop of SRSF9/USP22/ZEB1 promotes the progression of ovarian cancer16
Long-term effects of neoadjuvant chemotherapy in variant histology locally advanced colon cancer: a propensity score-matched analysis16
CRC-derived exosomes containing the RNA binding protein HuR promote lung cell proliferation by stabilizing c-Myc mRNA15
Correction15
NRSN2 promotes the malignant behavior of HPV-transfected laryngeal carcinoma cells through AMPK/ULK1 pathway mediated autophagy activation15
Clock in radiation oncology clinics: cost-free modality to alleviate treatment-related toxicity15
The impact of drug-eluting bead (vs. conventional) transarterial chemoembolization on hepatic fibrosis in treating intermediate or advanced hepatocellular carcinoma15
Navigating precision: the crucial role of next-generation sequencing recurrence risk assessment in tailoring adjuvant therapy for hormone receptor-positive, human epidermal growth factor Receptor2-neg15
NDUFA4L2 reduces mitochondrial respiration resulting in defective lysosomal trafficking in clear cell renal cell carcinoma15
DLAT promotes triple-negative breast cancer progression via YAP1 activation14
CD8α Structural Domains Enhance GUCY2C CAR-T Cell Efficacy14
Prognostic value of pretreatment procalcitonin and neutrophil–lymphocyte ratio in extensive-stage small-cell lung cancer14
SOX2 inhibits LLGL2 polarity protein in esophageal squamous cell carcinoma via miRNA-142-3p14
The critical role of tumor microbiome in cancer immunotherapy14
The anticancer mechanisms of Toxoplasma gondii rhoptry protein 16 on lung adenocarcinoma cells14
Acquired resistance to crizotinib in novel CDK14-ALK and CLTC-ALK fusions of ALK-positive large B-cell lymphoma identified by next-generation sequencing14
Plasma KRAS mutations predict the early recurrence after surgical resection of pancreatic cancer14
Novel specific activity-based probes validate KLK proteases as druggable targets13
HSF1 is involved in immunotherapeutic response through regulating APOJ/STAT3-mediated PD-L1 expression in hepatocellular carcinoma13
Effect of extracellular vesicle ZNF280B derived from lung cancer stem cells on lung cancer progression13
Cyclin-dependent kinase 7/9 inhibitor SNS-032 induces apoptosis in diffuse large B-cell lymphoma cells13
MiR-378a-5p exerts a radiosensitizing effect on CRC through LRP8/β-catenin axis13
High tumor amplification burden is associated with TP53 mutations in the pan-cancer setting13
WYC-209 inhibited GC malignant progression by down-regulating WNT4 through RARα13
CDK2 inhibition disorders centrosome stoichiometry and alters cellular outcomes in aneuploid cancer cells13
β-amino acid substitution in the SIINFEKL antigen alters immunological recognition13
Flotillin-1 enhances radioresistance through reducing radiation-induced DNA damage and promoting immune escape via STING signaling pathway in non-small cell lung cancer13
Single whole genome sequencing analysis blazes the trail for precision medicine12
Agent-based modeling in cancer biomedicine: applications and tools for calibration and validation12
CircSETD2 inhibits YAP1 by interaction with HuR during breast cancer progression12
Targeting mitochondrial tyrosyl-tRNA synthetase YARS2 suppresses colorectal cancer progression12
CX43 down-regulation promotes cell aggressiveness and 5-fluorouracil-resistance by attenuating cell stiffness in colorectal carcinoma12
Cancer-associated fibroblasts derived extracellular vesicles promote angiogenesis of colorectal adenocarcinoma cells through miR-135b-5p/FOXO1 axis12
Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance12
The human microbiome and cancer: a diagnostic and therapeutic perspective12
Correction12
Association between the IL1B-511 C>T polymorphism and the risk of hematologic malignancies: data from a meta-analysis11
Feasibility and safety of targeting mitochondria for cancer therapy – preclinical characterization of gamitrinib, a first-in-class, mitochondriaL-targeted small molecule Hsp90 inhibitor11
Real-time luminescence enables continuous drug–response analysis in adherent and suspension cell lines11
MGAT4EP promotes tumor progression and serves as a prognostic marker for breast cancer11
Repression of the SUMO-conjugating enzyme UBC9 is associated with lowered double minutes and reduced tumor progression11
CircATP5C1 promotes triple-negative breast cancer progression by binding IGF2BP2 to modulate CSF-1 secretion11
Correction10
Roles of TRPM channels in glioma10
Angiotensin receptor blockade and stereotactic body radiation therapy for early stage lung cancer ARB & SBRT for early stage lung cancer10
MiR-18a-5p attenuates HER2-positive breast cancer development by regulating PI3K/AKT pathway10
Salidroside inhibited the proliferation of gastric cancer cells through up-regulating tumor suppressor miR-1343-3p and down-regulating MAP3K6/MMP24 signal molecules10
Establishment of a visualized mouse orthotopic xenograft model of nasopharyngeal carcinoma10
Integrating DOI in T classification improves the predictive performance of laryngeal cancer staging9
Chaperonin containing TCP1 subunit 6A may activate Notch and Wnt pathways to facilitate the malignant behaviors and cancer stemness in oral squamous cell carcinoma9
Repeated treatments of Capan-1 cells with PARP1 and Chk1 inhibitors promote drug resistance, migration and invasion9
First-line treatments for KRAS-mutant non-small cell lung cancer: current state and future perspectives9
Netrin-1 inducing antiapoptotic effect of acute myeloid leukemia cells in a concentration-dependent manner through the Unc-5 netrin receptor B-focal adhesion kinase axis9
Amino-truncated NOV expression and its correlation with clinicopathologic features, prognosis, metastasis, and chemoresistance in bladder cancer9
Clinical significance of WT1 in the evaluation of therapeutic effect and prognosis of non-M3 acute myeloid leukemia9
TP53AIP1 induce autophagy via the AKT/mTOR signaling pathway in the breast cancer cells9
Dead or alive? Pitfall of survival analysis with TCGA datasets9
Knockdown of NDUFAF6 inhibits breast cancer progression via promoting mitophagy and apoptosis9
CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells9
M6A-mediated molecular patterns and tumor microenvironment infiltration characterization in nasopharyngeal carcinoma9
Influence of genetic polymorphisms in vascular endothelial-related genes on the clinical outcome of axitinib in patients with metastatic renal cell carcinoma9
0.31137585639954